nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2B6—Raloxifene—osteoporosis	0.127	0.177	CbGbCtD
Perhexiline—CYP2B6—Ethinyl Estradiol—osteoporosis	0.123	0.171	CbGbCtD
Perhexiline—CYP2B6—Cholecalciferol—osteoporosis	0.0983	0.137	CbGbCtD
Perhexiline—CYP3A4—Estropipate—osteoporosis	0.0586	0.0815	CbGbCtD
Perhexiline—CYP3A4—Calcitriol—osteoporosis	0.0586	0.0815	CbGbCtD
Perhexiline—CYP2D6—Cholecalciferol—osteoporosis	0.0475	0.066	CbGbCtD
Perhexiline—CYP3A4—Ergocalciferol—osteoporosis	0.0469	0.0651	CbGbCtD
Perhexiline—CYP3A4—Raloxifene—osteoporosis	0.0391	0.0544	CbGbCtD
Perhexiline—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0378	0.0525	CbGbCtD
Perhexiline—CYP3A4—Cholecalciferol—osteoporosis	0.0302	0.042	CbGbCtD
Perhexiline—CYP3A4—Conjugated Estrogens—osteoporosis	0.0277	0.0385	CbGbCtD
Perhexiline—CYP3A4—Estradiol—osteoporosis	0.0244	0.0338	CbGbCtD
Perhexiline—CPT2—Fatty Acid Beta Oxidation—GPD2—osteoporosis	0.0129	0.126	CbGpPWpGaD
Perhexiline—CPT1A—Fatty Acid Beta Oxidation—GPD2—osteoporosis	0.00893	0.0872	CbGpPWpGaD
Perhexiline—CPT2—Fatty Acid Beta Oxidation—TPI1—osteoporosis	0.00706	0.0689	CbGpPWpGaD
Perhexiline—CPT1A—Fatty Acid Beta Oxidation—TPI1—osteoporosis	0.00489	0.0478	CbGpPWpGaD
Perhexiline—Optic neuritis—Estropipate—osteoporosis	0.00455	0.0256	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—ID4—osteoporosis	0.00375	0.0366	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—GPD2—osteoporosis	0.00339	0.0331	CbGpPWpGaD
Perhexiline—Optic neuritis—Conjugated Estrogens—osteoporosis	0.003	0.0169	CcSEcCtD
Perhexiline—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00291	0.0284	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—osteoporosis	0.00264	0.0258	CbGpPWpGaD
Perhexiline—Weight decreased—Ergocalciferol—osteoporosis	0.00247	0.0139	CcSEcCtD
Perhexiline—Optic neuritis—Estradiol—osteoporosis	0.0024	0.0135	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—GPD2—osteoporosis	0.00235	0.023	CbGpPWpGaD
Perhexiline—Syncope—Calcium Acetate—osteoporosis	0.00193	0.0108	CcSEcCtD
Perhexiline—Loss of consciousness—Calcium Acetate—osteoporosis	0.00189	0.0106	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—osteoporosis	0.00183	0.0179	CbGpPWpGaD
Perhexiline—Neuropathy peripheral—Etidronic acid—osteoporosis	0.00177	0.00996	CcSEcCtD
Perhexiline—CPT2—PPAR Alpha Pathway—MYC—osteoporosis	0.00176	0.0172	CbGpPWpGaD
Perhexiline—Shock—Calcium Acetate—osteoporosis	0.00173	0.00971	CcSEcCtD
Perhexiline—Anorexia—Calcium Acetate—osteoporosis	0.00167	0.00941	CcSEcCtD
Perhexiline—Paraesthesia—Calcium Acetate—osteoporosis	0.00158	0.00887	CcSEcCtD
Perhexiline—Neuropathy peripheral—Estropipate—osteoporosis	0.00153	0.00862	CcSEcCtD
Perhexiline—Decreased appetite—Calcium Acetate—osteoporosis	0.00153	0.00858	CcSEcCtD
Perhexiline—Weight decreased—Ibandronate—osteoporosis	0.00152	0.00855	CcSEcCtD
Perhexiline—Gait disturbance—Estradiol—osteoporosis	0.00152	0.00852	CcSEcCtD
Perhexiline—Weight decreased—Calcitriol—osteoporosis	0.00149	0.00837	CcSEcCtD
Perhexiline—Anorexia—Ergocalciferol—osteoporosis	0.00148	0.00831	CcSEcCtD
Perhexiline—Sweating—Raloxifene—osteoporosis	0.00145	0.00816	CcSEcCtD
Perhexiline—Sweating—Ibandronate—osteoporosis	0.00144	0.00808	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00143	0.0139	CbGpPWpGaD
Perhexiline—Muscular weakness—Risedronate—osteoporosis	0.00141	0.00795	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00135	0.0132	CbGpPWpGaD
Perhexiline—Decreased appetite—Ergocalciferol—osteoporosis	0.00135	0.00758	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00133	0.013	CbGpPWpGaD
Perhexiline—Weight decreased—Ethinyl Estradiol—osteoporosis	0.00129	0.00723	CcSEcCtD
Perhexiline—Flushing—Raloxifene—osteoporosis	0.00126	0.0071	CcSEcCtD
Perhexiline—Asthenia—Calcium Acetate—osteoporosis	0.00126	0.00708	CcSEcCtD
Perhexiline—Neuropathy peripheral—Ethinyl Estradiol—osteoporosis	0.00124	0.00699	CcSEcCtD
Perhexiline—Muscular weakness—Zoledronate—osteoporosis	0.00123	0.00691	CcSEcCtD
Perhexiline—CPT1A—PPAR Alpha Pathway—MYC—osteoporosis	0.00122	0.0119	CbGpPWpGaD
Perhexiline—Tension—Estropipate—osteoporosis	0.0012	0.00674	CcSEcCtD
Perhexiline—Nervousness—Estropipate—osteoporosis	0.00119	0.00667	CcSEcCtD
Perhexiline—Dizziness—Calcium Acetate—osteoporosis	0.00116	0.00653	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—LEP—osteoporosis	0.00113	0.011	CbGpPWpGaD
Perhexiline—Vomiting—Calcium Acetate—osteoporosis	0.00112	0.00628	CcSEcCtD
Perhexiline—Asthenia—Ergocalciferol—osteoporosis	0.00111	0.00626	CcSEcCtD
Perhexiline—Weight decreased—Zoledronate—osteoporosis	0.00109	0.00612	CcSEcCtD
Perhexiline—Syncope—Raloxifene—osteoporosis	0.00106	0.00597	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.00105	0.0103	CbGpPWpGaD
Perhexiline—Nausea—Calcium Acetate—osteoporosis	0.00104	0.00586	CcSEcCtD
Perhexiline—Loss of consciousness—Raloxifene—osteoporosis	0.00104	0.00585	CcSEcCtD
Perhexiline—Paraesthesia—Etidronic acid—osteoporosis	0.00104	0.00582	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00102	0.01	CbGpPWpGaD
Perhexiline—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	0.00101	0.00569	CcSEcCtD
Perhexiline—Convulsion—Calcitriol—osteoporosis	0.000994	0.00559	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000988	0.00965	CbGpPWpGaD
Perhexiline—Flushing—Pamidronate—osteoporosis	0.000979	0.0055	CcSEcCtD
Perhexiline—Shock—Raloxifene—osteoporosis	0.000951	0.00534	CcSEcCtD
Perhexiline—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000943	0.0053	CcSEcCtD
Perhexiline—Shock—Ibandronate—osteoporosis	0.000941	0.00529	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000937	0.00915	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Raloxifene—osteoporosis	0.000934	0.00525	CcSEcCtD
Perhexiline—Hyperhidrosis—Ibandronate—osteoporosis	0.000925	0.0052	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000925	0.00903	CbGpPWpGaD
Perhexiline—Nausea—Ergocalciferol—osteoporosis	0.000922	0.00518	CcSEcCtD
Perhexiline—Urticaria—Etidronic acid—osteoporosis	0.000916	0.00515	CcSEcCtD
Perhexiline—Abdominal pain—Etidronic acid—osteoporosis	0.000912	0.00512	CcSEcCtD
Perhexiline—Insomnia—Estropipate—osteoporosis	0.000902	0.00507	CcSEcCtD
Perhexiline—Tension—Pamidronate—osteoporosis	0.000901	0.00507	CcSEcCtD
Perhexiline—Paraesthesia—Estropipate—osteoporosis	0.000896	0.00504	CcSEcCtD
Perhexiline—Flushing—Zoledronate—osteoporosis	0.000894	0.00503	CcSEcCtD
Perhexiline—Anorexia—Calcitriol—osteoporosis	0.000893	0.00502	CcSEcCtD
Perhexiline—Nervousness—Pamidronate—osteoporosis	0.000892	0.00501	CcSEcCtD
Perhexiline—Insomnia—Raloxifene—osteoporosis	0.000874	0.00491	CcSEcCtD
Perhexiline—Syncope—Risedronate—osteoporosis	0.000866	0.00487	CcSEcCtD
Perhexiline—Insomnia—Ibandronate—osteoporosis	0.000865	0.00486	CcSEcCtD
Perhexiline—Fatigue—Estropipate—osteoporosis	0.00086	0.00483	CcSEcCtD
Perhexiline—Paraesthesia—Ibandronate—osteoporosis	0.000859	0.00483	CcSEcCtD
Perhexiline—Loss of consciousness—Risedronate—osteoporosis	0.000849	0.00477	CcSEcCtD
Perhexiline—Insomnia—Calcitriol—osteoporosis	0.000847	0.00476	CcSEcCtD
Perhexiline—Weight decreased—Estradiol—osteoporosis	0.000839	0.00472	CcSEcCtD
Perhexiline—Decreased appetite—Ibandronate—osteoporosis	0.000832	0.00467	CcSEcCtD
Perhexiline—Fatigue—Ibandronate—osteoporosis	0.000825	0.00464	CcSEcCtD
Perhexiline—Syncope—Pamidronate—osteoporosis	0.000824	0.00463	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000819	0.008	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Estropipate—osteoporosis	0.000816	0.00459	CcSEcCtD
Perhexiline—Decreased appetite—Calcitriol—osteoporosis	0.000814	0.00458	CcSEcCtD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000812	0.00793	CbGpPWpGaD
Perhexiline—Neuropathy peripheral—Estradiol—osteoporosis	0.000811	0.00456	CcSEcCtD
Perhexiline—Loss of consciousness—Pamidronate—osteoporosis	0.000807	0.00454	CcSEcCtD
Perhexiline—Gastrointestinal pain—Alendronate—osteoporosis	0.000804	0.00452	CcSEcCtD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000802	0.00783	CbGpPWpGaD
Perhexiline—Convulsion—Pamidronate—osteoporosis	0.000796	0.00447	CcSEcCtD
Perhexiline—Tension—Conjugated Estrogens—osteoporosis	0.000793	0.00445	CcSEcCtD
Perhexiline—Urticaria—Estropipate—osteoporosis	0.000793	0.00445	CcSEcCtD
Perhexiline—Gastrointestinal pain—Raloxifene—osteoporosis	0.00079	0.00444	CcSEcCtD
Perhexiline—Abdominal pain—Estropipate—osteoporosis	0.000789	0.00443	CcSEcCtD
Perhexiline—Tremor—Zoledronate—osteoporosis	0.000786	0.00442	CcSEcCtD
Perhexiline—Nervousness—Conjugated Estrogens—osteoporosis	0.000785	0.00441	CcSEcCtD
Perhexiline—Gastrointestinal pain—Ibandronate—osteoporosis	0.000782	0.0044	CcSEcCtD
Perhexiline—Urticaria—Alendronate—osteoporosis	0.000781	0.00439	CcSEcCtD
Perhexiline—Abdominal pain—Alendronate—osteoporosis	0.000777	0.00437	CcSEcCtD
Perhexiline—Shock—Risedronate—osteoporosis	0.000776	0.00436	CcSEcCtD
Perhexiline—Gastrointestinal pain—Calcitriol—osteoporosis	0.000766	0.0043	CcSEcCtD
Perhexiline—Abdominal pain—Raloxifene—osteoporosis	0.000764	0.00429	CcSEcCtD
Perhexiline—Urticaria—Ibandronate—osteoporosis	0.00076	0.00427	CcSEcCtD
Perhexiline—Abdominal pain—Ibandronate—osteoporosis	0.000756	0.00425	CcSEcCtD
Perhexiline—Syncope—Zoledronate—osteoporosis	0.000752	0.00423	CcSEcCtD
Perhexiline—Urticaria—Calcitriol—osteoporosis	0.000744	0.00418	CcSEcCtD
Perhexiline—Hepatitis—Estradiol—osteoporosis	0.000743	0.00417	CcSEcCtD
Perhexiline—Abdominal pain—Calcitriol—osteoporosis	0.00074	0.00416	CcSEcCtD
Perhexiline—Shock—Pamidronate—osteoporosis	0.000737	0.00414	CcSEcCtD
Perhexiline—Loss of consciousness—Zoledronate—osteoporosis	0.000737	0.00414	CcSEcCtD
Perhexiline—Vomiting—Etidronic acid—osteoporosis	0.000733	0.00412	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000729	0.00712	CbGpPWpGaD
Perhexiline—Rash—Etidronic acid—osteoporosis	0.000727	0.00409	CcSEcCtD
Perhexiline—Convulsion—Zoledronate—osteoporosis	0.000727	0.00409	CcSEcCtD
Perhexiline—Dermatitis—Etidronic acid—osteoporosis	0.000726	0.00408	CcSEcCtD
Perhexiline—Hyperhidrosis—Pamidronate—osteoporosis	0.000725	0.00407	CcSEcCtD
Perhexiline—Syncope—Conjugated Estrogens—osteoporosis	0.000724	0.00407	CcSEcCtD
Perhexiline—Headache—Etidronic acid—osteoporosis	0.000722	0.00406	CcSEcCtD
Perhexiline—Asthenia—Estropipate—osteoporosis	0.000716	0.00402	CcSEcCtD
Perhexiline—Anorexia—Pamidronate—osteoporosis	0.000714	0.00402	CcSEcCtD
Perhexiline—Insomnia—Risedronate—osteoporosis	0.000713	0.00401	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00071	0.00693	CbGpPWpGaD
Perhexiline—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00071	0.00399	CcSEcCtD
Perhexiline—Paraesthesia—Risedronate—osteoporosis	0.000708	0.00398	CcSEcCtD
Perhexiline—Asthenia—Alendronate—osteoporosis	0.000705	0.00396	CcSEcCtD
Perhexiline—Convulsion—Conjugated Estrogens—osteoporosis	0.0007	0.00393	CcSEcCtD
Perhexiline—Fatigue—Ethinyl Estradiol—osteoporosis	0.000697	0.00392	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000696	0.0068	CbGpPWpGaD
Perhexiline—Flushing—Estradiol—osteoporosis	0.000689	0.00387	CcSEcCtD
Perhexiline—Asthenia—Ibandronate—osteoporosis	0.000686	0.00386	CcSEcCtD
Perhexiline—Nausea—Etidronic acid—osteoporosis	0.000685	0.00385	CcSEcCtD
Perhexiline—Fatigue—Risedronate—osteoporosis	0.00068	0.00382	CcSEcCtD
Perhexiline—Insomnia—Pamidronate—osteoporosis	0.000678	0.00381	CcSEcCtD
Perhexiline—Shock—Zoledronate—osteoporosis	0.000674	0.00379	CcSEcCtD
Perhexiline—Paraesthesia—Pamidronate—osteoporosis	0.000673	0.00378	CcSEcCtD
Perhexiline—Asthenia—Calcitriol—osteoporosis	0.000672	0.00378	CcSEcCtD
Perhexiline—Hyperhidrosis—Zoledronate—osteoporosis	0.000662	0.00372	CcSEcCtD
Perhexiline—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000661	0.00372	CcSEcCtD
Perhexiline—Dizziness—Estropipate—osteoporosis	0.00066	0.00371	CcSEcCtD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000659	0.00643	CbGpPWpGaD
Perhexiline—Anorexia—Zoledronate—osteoporosis	0.000653	0.00367	CcSEcCtD
Perhexiline—Decreased appetite—Pamidronate—osteoporosis	0.000652	0.00366	CcSEcCtD
Perhexiline—Dizziness—Alendronate—osteoporosis	0.00065	0.00365	CcSEcCtD
Perhexiline—Shock—Conjugated Estrogens—osteoporosis	0.000649	0.00365	CcSEcCtD
Perhexiline—Fatigue—Pamidronate—osteoporosis	0.000646	0.00363	CcSEcCtD
Perhexiline—Gastrointestinal pain—Risedronate—osteoporosis	0.000645	0.00362	CcSEcCtD
Perhexiline—Urticaria—Ethinyl Estradiol—osteoporosis	0.000642	0.00361	CcSEcCtD
Perhexiline—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000639	0.00359	CcSEcCtD
Perhexiline—Dizziness—Raloxifene—osteoporosis	0.000639	0.00359	CcSEcCtD
Perhexiline—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000637	0.00358	CcSEcCtD
Perhexiline—CPT2—Metabolism—PKM—osteoporosis	0.000635	0.0062	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—FDPS—osteoporosis	0.000635	0.0062	CbGpPWpGaD
Perhexiline—Tension—Estradiol—osteoporosis	0.000634	0.00357	CcSEcCtD
Perhexiline—Vomiting—Estropipate—osteoporosis	0.000634	0.00357	CcSEcCtD
Perhexiline—Dizziness—Ibandronate—osteoporosis	0.000633	0.00356	CcSEcCtD
Perhexiline—Rash—Estropipate—osteoporosis	0.000629	0.00354	CcSEcCtD
Perhexiline—Dermatitis—Estropipate—osteoporosis	0.000628	0.00353	CcSEcCtD
Perhexiline—Anorexia—Conjugated Estrogens—osteoporosis	0.000628	0.00353	CcSEcCtD
Perhexiline—Nervousness—Estradiol—osteoporosis	0.000628	0.00353	CcSEcCtD
Perhexiline—Urticaria—Risedronate—osteoporosis	0.000626	0.00352	CcSEcCtD
Perhexiline—Headache—Estropipate—osteoporosis	0.000625	0.00351	CcSEcCtD
Perhexiline—Vomiting—Alendronate—osteoporosis	0.000625	0.00351	CcSEcCtD
Perhexiline—Abdominal pain—Risedronate—osteoporosis	0.000623	0.0035	CcSEcCtD
Perhexiline—Rash—Alendronate—osteoporosis	0.00062	0.00348	CcSEcCtD
Perhexiline—Insomnia—Zoledronate—osteoporosis	0.000619	0.00348	CcSEcCtD
Perhexiline—Dermatitis—Alendronate—osteoporosis	0.000619	0.00348	CcSEcCtD
Perhexiline—Headache—Alendronate—osteoporosis	0.000616	0.00346	CcSEcCtD
Perhexiline—Paraesthesia—Zoledronate—osteoporosis	0.000615	0.00346	CcSEcCtD
Perhexiline—Vomiting—Raloxifene—osteoporosis	0.000614	0.00345	CcSEcCtD
Perhexiline—Gastrointestinal pain—Pamidronate—osteoporosis	0.000613	0.00344	CcSEcCtD
Perhexiline—Rash—Raloxifene—osteoporosis	0.000609	0.00342	CcSEcCtD
Perhexiline—Dermatitis—Raloxifene—osteoporosis	0.000609	0.00342	CcSEcCtD
Perhexiline—Vomiting—Ibandronate—osteoporosis	0.000608	0.00342	CcSEcCtD
Perhexiline—Tremor—Estradiol—osteoporosis	0.000606	0.0034	CcSEcCtD
Perhexiline—Headache—Raloxifene—osteoporosis	0.000605	0.0034	CcSEcCtD
Perhexiline—Rash—Ibandronate—osteoporosis	0.000603	0.00339	CcSEcCtD
Perhexiline—Dermatitis—Ibandronate—osteoporosis	0.000603	0.00339	CcSEcCtD
Perhexiline—CPT2—Metabolism—GPD2—osteoporosis	0.000602	0.00588	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PGLS—osteoporosis	0.000602	0.00588	CbGpPWpGaD
Perhexiline—Headache—Ibandronate—osteoporosis	0.000599	0.00337	CcSEcCtD
Perhexiline—Insomnia—Conjugated Estrogens—osteoporosis	0.000596	0.00335	CcSEcCtD
Perhexiline—Vomiting—Calcitriol—osteoporosis	0.000595	0.00335	CcSEcCtD
Perhexiline—Decreased appetite—Zoledronate—osteoporosis	0.000595	0.00334	CcSEcCtD
Perhexiline—Nausea—Estropipate—osteoporosis	0.000593	0.00333	CcSEcCtD
Perhexiline—Abdominal pain—Pamidronate—osteoporosis	0.000593	0.00333	CcSEcCtD
Perhexiline—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000592	0.00333	CcSEcCtD
Perhexiline—Rash—Calcitriol—osteoporosis	0.000591	0.00332	CcSEcCtD
Perhexiline—Fatigue—Zoledronate—osteoporosis	0.00059	0.00332	CcSEcCtD
Perhexiline—Dermatitis—Calcitriol—osteoporosis	0.00059	0.00332	CcSEcCtD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000588	0.00574	CbGpPWpGaD
Perhexiline—Headache—Calcitriol—osteoporosis	0.000587	0.0033	CcSEcCtD
Perhexiline—Nausea—Alendronate—osteoporosis	0.000584	0.00328	CcSEcCtD
Perhexiline—Asthenia—Ethinyl Estradiol—osteoporosis	0.00058	0.00326	CcSEcCtD
Perhexiline—Syncope—Estradiol—osteoporosis	0.00058	0.00326	CcSEcCtD
Perhexiline—Nausea—Raloxifene—osteoporosis	0.000574	0.00323	CcSEcCtD
Perhexiline—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000573	0.00322	CcSEcCtD
Perhexiline—Fatigue—Conjugated Estrogens—osteoporosis	0.000568	0.00319	CcSEcCtD
Perhexiline—Nausea—Ibandronate—osteoporosis	0.000568	0.00319	CcSEcCtD
Perhexiline—Loss of consciousness—Estradiol—osteoporosis	0.000568	0.00319	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000568	0.00554	CbGpPWpGaD
Perhexiline—Asthenia—Risedronate—osteoporosis	0.000566	0.00318	CcSEcCtD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000565	0.00551	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Zoledronate—osteoporosis	0.00056	0.00315	CcSEcCtD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000557	0.00544	CbGpPWpGaD
Perhexiline—Nausea—Calcitriol—osteoporosis	0.000556	0.00313	CcSEcCtD
Perhexiline—CPT2—Metabolism—ATIC—osteoporosis	0.000551	0.00538	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PNP—osteoporosis	0.000551	0.00538	CbGpPWpGaD
Perhexiline—Urticaria—Zoledronate—osteoporosis	0.000544	0.00306	CcSEcCtD
Perhexiline—Abdominal pain—Zoledronate—osteoporosis	0.000541	0.00304	CcSEcCtD
Perhexiline—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000539	0.00303	CcSEcCtD
Perhexiline—Asthenia—Pamidronate—osteoporosis	0.000538	0.00302	CcSEcCtD
Perhexiline—Dizziness—Ethinyl Estradiol—osteoporosis	0.000535	0.00301	CcSEcCtD
Perhexiline—Urticaria—Conjugated Estrogens—osteoporosis	0.000524	0.00294	CcSEcCtD
Perhexiline—Dizziness—Risedronate—osteoporosis	0.000521	0.00293	CcSEcCtD
Perhexiline—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000521	0.00293	CcSEcCtD
Perhexiline—Shock—Estradiol—osteoporosis	0.000519	0.00292	CcSEcCtD
Perhexiline—Vomiting—Ethinyl Estradiol—osteoporosis	0.000514	0.00289	CcSEcCtD
Perhexiline—Hyperhidrosis—Estradiol—osteoporosis	0.00051	0.00287	CcSEcCtD
Perhexiline—Rash—Ethinyl Estradiol—osteoporosis	0.00051	0.00287	CcSEcCtD
Perhexiline—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000509	0.00286	CcSEcCtD
Perhexiline—Headache—Ethinyl Estradiol—osteoporosis	0.000507	0.00285	CcSEcCtD
Perhexiline—Vomiting—Risedronate—osteoporosis	0.000501	0.00282	CcSEcCtD
Perhexiline—Rash—Risedronate—osteoporosis	0.000497	0.00279	CcSEcCtD
Perhexiline—Dermatitis—Risedronate—osteoporosis	0.000497	0.00279	CcSEcCtD
Perhexiline—Dizziness—Pamidronate—osteoporosis	0.000496	0.00279	CcSEcCtD
Perhexiline—Headache—Risedronate—osteoporosis	0.000494	0.00278	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000492	0.00481	CbGpPWpGaD
Perhexiline—Asthenia—Zoledronate—osteoporosis	0.000491	0.00276	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000483	0.00471	CbGpPWpGaD
Perhexiline—Nausea—Ethinyl Estradiol—osteoporosis	0.00048	0.0027	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—LEP—osteoporosis	0.00048	0.00468	CbGpPWpGaD
Perhexiline—Insomnia—Estradiol—osteoporosis	0.000477	0.00268	CcSEcCtD
Perhexiline—Vomiting—Pamidronate—osteoporosis	0.000477	0.00268	CcSEcCtD
Perhexiline—Paraesthesia—Estradiol—osteoporosis	0.000474	0.00266	CcSEcCtD
Perhexiline—Asthenia—Conjugated Estrogens—osteoporosis	0.000473	0.00266	CcSEcCtD
Perhexiline—Rash—Pamidronate—osteoporosis	0.000473	0.00266	CcSEcCtD
Perhexiline—Dermatitis—Pamidronate—osteoporosis	0.000472	0.00265	CcSEcCtD
Perhexiline—Headache—Pamidronate—osteoporosis	0.00047	0.00264	CcSEcCtD
Perhexiline—Nausea—Risedronate—osteoporosis	0.000468	0.00263	CcSEcCtD
Perhexiline—CPT2—Metabolism—OXCT1—osteoporosis	0.000468	0.00457	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CA2—osteoporosis	0.000468	0.00457	CbGpPWpGaD
Perhexiline—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000465	0.00454	CbGpPWpGaD
Perhexiline—Decreased appetite—Estradiol—osteoporosis	0.000459	0.00258	CcSEcCtD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000458	0.00447	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—MGLL—osteoporosis	0.000456	0.00446	CbGpPWpGaD
Perhexiline—Fatigue—Estradiol—osteoporosis	0.000455	0.00256	CcSEcCtD
Perhexiline—Dizziness—Zoledronate—osteoporosis	0.000453	0.00254	CcSEcCtD
Perhexiline—Nausea—Pamidronate—osteoporosis	0.000445	0.0025	CcSEcCtD
Perhexiline—CPT1A—Metabolism—PKM—osteoporosis	0.00044	0.0043	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—FDPS—osteoporosis	0.00044	0.0043	CbGpPWpGaD
Perhexiline—Dizziness—Conjugated Estrogens—osteoporosis	0.000436	0.00245	CcSEcCtD
Perhexiline—Vomiting—Zoledronate—osteoporosis	0.000435	0.00245	CcSEcCtD
Perhexiline—Rash—Zoledronate—osteoporosis	0.000432	0.00243	CcSEcCtD
Perhexiline—Gastrointestinal pain—Estradiol—osteoporosis	0.000431	0.00242	CcSEcCtD
Perhexiline—Dermatitis—Zoledronate—osteoporosis	0.000431	0.00242	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.00043	0.0042	CbGpPWpGaD
Perhexiline—Headache—Zoledronate—osteoporosis	0.000429	0.00241	CcSEcCtD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000427	0.00417	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000421	0.00411	CbGpPWpGaD
Perhexiline—Vomiting—Conjugated Estrogens—osteoporosis	0.000419	0.00236	CcSEcCtD
Perhexiline—Urticaria—Estradiol—osteoporosis	0.000419	0.00236	CcSEcCtD
Perhexiline—CPT1A—Metabolism—GPD2—osteoporosis	0.000417	0.00407	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PGLS—osteoporosis	0.000417	0.00407	CbGpPWpGaD
Perhexiline—Abdominal pain—Estradiol—osteoporosis	0.000417	0.00234	CcSEcCtD
Perhexiline—Rash—Conjugated Estrogens—osteoporosis	0.000416	0.00234	CcSEcCtD
Perhexiline—Dermatitis—Conjugated Estrogens—osteoporosis	0.000415	0.00233	CcSEcCtD
Perhexiline—Headache—Conjugated Estrogens—osteoporosis	0.000413	0.00232	CcSEcCtD
Perhexiline—Nausea—Zoledronate—osteoporosis	0.000407	0.00229	CcSEcCtD
Perhexiline—Nausea—Conjugated Estrogens—osteoporosis	0.000392	0.0022	CcSEcCtD
Perhexiline—CPT2—Metabolism—IDH2—osteoporosis	0.000388	0.00379	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PNP—osteoporosis	0.000382	0.00373	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ATIC—osteoporosis	0.000382	0.00373	CbGpPWpGaD
Perhexiline—Asthenia—Estradiol—osteoporosis	0.000379	0.00213	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000375	0.00366	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000369	0.0036	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP27A1—osteoporosis	0.000365	0.00356	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000364	0.00356	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ACP5—osteoporosis	0.000355	0.00346	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.00035	0.00342	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP27A1—osteoporosis	0.00035	0.00342	CbGpPWpGaD
Perhexiline—Dizziness—Estradiol—osteoporosis	0.000349	0.00196	CcSEcCtD
Perhexiline—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000348	0.0034	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000346	0.00338	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP27A1—osteoporosis	0.000345	0.00337	CbGpPWpGaD
Perhexiline—Vomiting—Estradiol—osteoporosis	0.000335	0.00189	CcSEcCtD
Perhexiline—Rash—Estradiol—osteoporosis	0.000333	0.00187	CcSEcCtD
Perhexiline—Dermatitis—Estradiol—osteoporosis	0.000332	0.00187	CcSEcCtD
Perhexiline—Headache—Estradiol—osteoporosis	0.000331	0.00186	CcSEcCtD
Perhexiline—CPT2—Metabolism—TPI1—osteoporosis	0.00033	0.00322	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—OXCT1—osteoporosis	0.000325	0.00317	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CA2—osteoporosis	0.000325	0.00317	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—MGLL—osteoporosis	0.000316	0.00309	CbGpPWpGaD
Perhexiline—Nausea—Estradiol—osteoporosis	0.000313	0.00176	CcSEcCtD
Perhexiline—CPT2—Metabolism—P4HB—osteoporosis	0.00031	0.00303	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GAPDH—osteoporosis	0.000304	0.00297	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000299	0.00292	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000298	0.00291	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000297	0.0029	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—RAP1A—osteoporosis	0.000297	0.0029	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000293	0.00286	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000272	0.00265	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—IDH2—osteoporosis	0.000269	0.00263	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000267	0.00261	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000259	0.00252	CbGpPWpGaD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000256	0.0025	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP27A1—osteoporosis	0.000253	0.00247	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ACP5—osteoporosis	0.000246	0.0024	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	0.000243	0.00237	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000243	0.00237	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00024	0.00235	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.00024	0.00234	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	0.00024	0.00234	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ENO1—osteoporosis	0.00024	0.00234	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PSMA5—osteoporosis	0.000236	0.00231	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PSMA2—osteoporosis	0.000236	0.00231	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—TPI1—osteoporosis	0.000229	0.00223	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000219	0.00214	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—P4HB—osteoporosis	0.000215	0.0021	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GAPDH—osteoporosis	0.000211	0.00206	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000208	0.00203	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—RAP1A—osteoporosis	0.000206	0.00201	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000194	0.00189	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP19A1—osteoporosis	0.000192	0.00187	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000191	0.00187	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP19A1—osteoporosis	0.000184	0.00179	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP19A1—osteoporosis	0.000181	0.00177	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000179	0.00175	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—IL6—osteoporosis	0.000179	0.00175	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000178	0.00174	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ENO1—osteoporosis	0.000166	0.00162	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PSMA2—osteoporosis	0.000164	0.0016	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PSMA5—osteoporosis	0.000164	0.0016	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000159	0.00155	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000157	0.00154	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000157	0.00153	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ADCY5—osteoporosis	0.000157	0.00153	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GPX1—osteoporosis	0.000156	0.00152	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000145	0.00141	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—MTHFR—osteoporosis	0.000144	0.00141	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP19A1—osteoporosis	0.000133	0.0013	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	0.000128	0.00125	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	0.000126	0.00123	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000117	0.00114	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—POMC—osteoporosis	0.000115	0.00112	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—POMC—osteoporosis	0.00011	0.00108	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ADCY5—osteoporosis	0.000109	0.00106	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GPX1—osteoporosis	0.000108	0.00106	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—FDPS—osteoporosis	0.000104	0.00102	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PKM—osteoporosis	0.000104	0.00102	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—MTHFR—osteoporosis	9.98e-05	0.000975	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PGLS—osteoporosis	9.88e-05	0.000964	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GPD2—osteoporosis	9.88e-05	0.000964	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.45e-05	0.000923	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ATIC—osteoporosis	9.03e-05	0.000882	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PNP—osteoporosis	9.03e-05	0.000882	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	8.35e-05	0.000815	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	8.24e-05	0.000804	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—POMC—osteoporosis	7.98e-05	0.000779	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CA2—osteoporosis	7.68e-05	0.00075	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—OXCT1—osteoporosis	7.68e-05	0.00075	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—POMC—osteoporosis	7.68e-05	0.00075	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MGLL—osteoporosis	7.48e-05	0.000731	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PKM—osteoporosis	7.24e-05	0.000707	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—FDPS—osteoporosis	7.24e-05	0.000707	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PGLS—osteoporosis	6.86e-05	0.00067	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GPD2—osteoporosis	6.86e-05	0.00067	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—IDH2—osteoporosis	6.36e-05	0.000621	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ATIC—osteoporosis	6.28e-05	0.000613	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PNP—osteoporosis	6.28e-05	0.000613	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP27A1—osteoporosis	5.98e-05	0.000584	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ACP5—osteoporosis	5.82e-05	0.000568	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TPI1—osteoporosis	5.41e-05	0.000528	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—OXCT1—osteoporosis	5.34e-05	0.000521	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CA2—osteoporosis	5.34e-05	0.000521	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MGLL—osteoporosis	5.2e-05	0.000508	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—P4HB—osteoporosis	5.09e-05	0.000497	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—POMC—osteoporosis	5.02e-05	0.00049	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GAPDH—osteoporosis	4.99e-05	0.000488	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—RAP1A—osteoporosis	4.86e-05	0.000475	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PKM—osteoporosis	4.73e-05	0.000462	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—FDPS—osteoporosis	4.73e-05	0.000462	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GPD2—osteoporosis	4.49e-05	0.000438	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PGLS—osteoporosis	4.49e-05	0.000438	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—IDH2—osteoporosis	4.42e-05	0.000432	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP27A1—osteoporosis	4.16e-05	0.000406	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PNP—osteoporosis	4.1e-05	0.000401	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ATIC—osteoporosis	4.1e-05	0.000401	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ACP5—osteoporosis	4.05e-05	0.000395	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ENO1—osteoporosis	3.93e-05	0.000384	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PSMA2—osteoporosis	3.87e-05	0.000378	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PSMA5—osteoporosis	3.87e-05	0.000378	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TPI1—osteoporosis	3.76e-05	0.000367	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—P4HB—osteoporosis	3.54e-05	0.000345	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CA2—osteoporosis	3.49e-05	0.000341	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—OXCT1—osteoporosis	3.49e-05	0.000341	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GAPDH—osteoporosis	3.47e-05	0.000339	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MGLL—osteoporosis	3.4e-05	0.000332	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—RAP1A—osteoporosis	3.38e-05	0.00033	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP19A1—osteoporosis	3.14e-05	0.000307	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—IDH2—osteoporosis	2.89e-05	0.000282	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ENO1—osteoporosis	2.73e-05	0.000267	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.72e-05	0.000265	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PSMA2—osteoporosis	2.69e-05	0.000263	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PSMA5—osteoporosis	2.69e-05	0.000263	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ACP5—osteoporosis	2.64e-05	0.000258	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ADCY5—osteoporosis	2.57e-05	0.000251	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GPX1—osteoporosis	2.56e-05	0.00025	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TPI1—osteoporosis	2.46e-05	0.00024	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MTHFR—osteoporosis	2.36e-05	0.000231	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—P4HB—osteoporosis	2.31e-05	0.000226	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GAPDH—osteoporosis	2.27e-05	0.000222	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—RAP1A—osteoporosis	2.21e-05	0.000216	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP19A1—osteoporosis	2.18e-05	0.000213	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—POMC—osteoporosis	1.89e-05	0.000184	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ENO1—osteoporosis	1.79e-05	0.000174	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ADCY5—osteoporosis	1.78e-05	0.000174	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GPX1—osteoporosis	1.78e-05	0.000174	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PSMA5—osteoporosis	1.76e-05	0.000172	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PSMA2—osteoporosis	1.76e-05	0.000172	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MTHFR—osteoporosis	1.64e-05	0.00016	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.43e-05	0.000139	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—POMC—osteoporosis	1.31e-05	0.000128	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ADCY5—osteoporosis	1.17e-05	0.000114	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GPX1—osteoporosis	1.16e-05	0.000114	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MTHFR—osteoporosis	1.07e-05	0.000105	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—POMC—osteoporosis	8.58e-06	8.38e-05	CbGpPWpGaD
